Atlas Trials

Effect of Hydralazine on Alzheimer's Disease

Clinical trial NCT04842552 · UNKNOWN

Trial details

NCT number
NCT04842552
Sponsor
Shahid Sadoughi University of Medical Sciences and Health Services
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2021-08-02
Primary completion
2023-06-01
Enrollment
424

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.